Investments in Financial Assets |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Investments in Financial Assets | |
| Investments in Financial Assets | 17. Investments in Financial Assets Investment in financial assets consist of the Company’s investment in Kamal Therapeutics Inc. (“Kamal”) and Yarrow Biotechnology Inc. (“Yarrow”). ProQR holds a 0.28% interest in Kamal. As at June 30, 2026, the investment amounts to € nil (December 31, 2025: € nil). ProQR holds a 3.6% interest in Yarrow. As at June 30, 2026, the fair value of the Yarrow financial asset amounted to € nil (December 31, 2025: € nil). |